LGND
NASDAQ · Pharmaceuticals
Ligand Pharmaceuticals
$204.56
+2.90 (+1.44%)
Performance
1D
—
1W
—
1M
—
3M
+4.46%
6M
+18.15%
1Y
+89.25%
YTD
+7.60%
Open$203.17
Previous Close$201.66
Day High$208.89
Day Low$201.28
52W High$212.49
52W Low$93.58
Volume—
Avg Volume201.1K
Market Cap3.69B
P/E Ratio76.03
EPS$2.08
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$193.47
Above
SMA 200
$162.08
Above
RSI (14)
38.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
-84.6% upside
Current
$204.56
$204.56
Target
$31.56
$31.56
$18.80
$31.56 avg
$35.41
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 177.23M | 209.76M | 944.72M |
| Net Income | -4,274,642 | -4,553,412 | 258.92M |
| Profit Margin | -2.4% | -2.3% | 27.4% |
| EBITDA | -31,291,776 | -35,184,267 | 346.84M |
| Free Cash Flow | — | — | 167.31M |
| Rev Growth | -15.5% | -15.5% | +8.5% |
| Debt/Equity | — | — | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |